Organo Statistics

Total Valuation

Organo has a market cap or net worth of JPY 292.80 billion. The enterprise value is 311.35 billion.

Market Cap	292.80B
Enterprise Value	311.35B

Important Dates

The next estimated earnings date is Tuesday, May 13, 2025.

Earnings Date	May 13, 2025
Ex-Dividend Date	Mar 28, 2025

Share Statistics

Organo has 45.97 million shares outstanding. The number of shares has increased by 0.11% in one year.

Current Share Class	n/a
Shares Outstanding	45.97M
Shares Change (YoY)	+0.11%
Shares Change (QoQ)	-0.02%
Owned by Insiders (%)	0.24%
Owned by Institutions (%)	21.20%
Float	25.48M

Valuation Ratios

The trailing PE ratio is 13.93 and the forward PE ratio is 12.85.

PE Ratio	13.93
Forward PE	12.85
PS Ratio	1.83
PB Ratio	2.68
P/TBV Ratio	2.70
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	14.81
EV / Sales	1.95
EV / EBITDA	10.24
EV / EBIT	11.02
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.26, with a Debt / Equity ratio of 0.30.

Current Ratio	2.26
Quick Ratio	1.90
Debt / Equity	0.30
Debt / EBITDA	1.10
Debt / FCF	n/a
Interest Coverage	111.06

Financial Efficiency

Return on equity (ROE) is 20.62% and return on invested capital (ROIC) is 12.74%.

Return on Equity (ROE)	20.62%
Return on Assets (ROA)	9.64%
Return on Invested Capital (ROIC)	12.74%
Return on Capital Employed (ROCE)	24.14%
Revenue Per Employee	63.62M
Profits Per Employee	8.37M
Employee Count	2,512
Asset Turnover	0.88
Inventory Turnover	5.20

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -7.10% in the last 52 weeks. The beta is 0.76, so Organo's price volatility has been lower than the market average.

Beta (5Y)	0.76
52-Week Price Change	-7.10%
50-Day Moving Average	7,385.40
200-Day Moving Average	7,584.60
Relative Strength Index (RSI)	42.83
Average Volume (20 Days)	271,530

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Organo had revenue of JPY 159.82 billion and earned 21.03 billion in profits. Earnings per share was 457.44.

Revenue	159.82B
Gross Profit	51.31B
Operating Income	28.10B
Pretax Income	29.30B
Net Income	21.03B
EBITDA	30.25B
EBIT	28.10B
Earnings Per Share (EPS)	457.44

Full Income Statement

Balance Sheet

The company has 14.84 billion in cash and 33.14 billion in debt, giving a net cash position of -18.31 billion or -398.23 per share.

Cash & Cash Equivalents	14.84B
Total Debt	33.14B
Net Cash	-18.31B
Net Cash Per Share	-398.23
Equity (Book Value)	109.66B
Book Value Per Share	2,380.29
Working Capital	86.63B

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 32.11%, with operating and profit margins of 17.58% and 13.16%.

Gross Margin	32.11%
Operating Margin	17.58%
Pretax Margin	18.34%
Profit Margin	13.16%
EBITDA Margin	18.93%
EBIT Margin	17.58%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 142.00, which amounts to a dividend yield of 2.09%.

Dividend Per Share	142.00
Dividend Yield	2.09%
Dividend Growth (YoY)	39.22%
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	-0.11%
Shareholder Yield	1.98%
Earnings Yield	7.18%
FCF Yield	n/a

Dividend Details

Stock Splits

The last stock split was on September 29, 2022. It was a forward split with a ratio of 4.

Last Split Date	Sep 29, 2022
Split Type	Forward
Split Ratio	4

Scores

Organo has an Altman Z-Score of 5.33.

Altman Z-Score	5.33
Piotroski F-Score	n/a